Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
about
Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expressionRiluzole elevates GLT-1 activity and levels in striatal astrocytesResveratrol: A Focus on Several Neurodegenerative DiseasesThe Sur1-Trpm4 Channel in Spinal Cord InjuryGlutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis.Past, present and future therapeutics for cerebellar ataxias.In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.Inhibiting drug efflux transporters improves efficacy of ALS therapeuticsMotor neuron degeneration promotes neural progenitor cell proliferation, migration, and neurogenesis in the spinal cords of amyotrophic lateral sclerosis mice.Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element.The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis.Riluzole in psychiatry: a systematic review of the literature.FTD and ALS: a tale of two diseasesA(a)LS: Ammonia-induced amyotrophic lateral sclerosis.A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression.Potential new complication in drug therapy development for amyotrophic lateral sclerosis.PGC-1α Silencing Compounds the Perturbation of Mitochondrial Function Caused by Mutant SOD1 in Skeletal Muscle of ALS Mouse Model.From muscle research to clinical applications: Do glutamate antagonists aid muscle recovery?Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.Gene transfer of GLT-1, a glial glutamate transporter, into the spinal cord by recombinant adenovirus attenuates inflammatory and neuropathic pain in rats.Targeting glial physiology and glutamate cycling in the treatment of depression.Current and emerging treatments for amyotrophic lateral sclerosis.SOX9 Is an Astrocyte-Specific Nuclear Marker in the Adult Brain Outside the Neurogenic Regions.Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice.The Bcl-2 Homology-3 Domain (BH3)-Only Proteins, Bid, DP5/Hrk, and BNip3L, Are Upregulated in Reactive Astrocytes of End-Stage Mutant SOD1 Mouse Spinal Cord.
P2860
Q24595928-60F75D10-2549-4C17-844D-4D9BECB33EE4Q24610013-EFFC53B9-27E1-4EC2-A2B1-CA9149F9C520Q26800952-88AA9DDA-0D47-41C9-A4A2-AEC1B30E7BCFQ33602457-E06EA59A-DEAC-4667-BA69-169C10924CDCQ33742729-41FB2C11-E2C9-455E-A3B2-FDBA6233031AQ33836935-48E9D84A-2935-4E83-ADD3-E42DC30EA488Q33980357-5E7E6F4B-08E4-42B9-ADC1-AB6A3291A289Q34824777-0E35C2A7-729A-4BC5-AD25-9C153C562467Q35688106-99051A34-4B18-4559-8949-1FA5E3A4BAA2Q35737505-376AAA84-D5D4-401D-AA02-DFA84CAE1E19Q36014767-BA7DC3A5-3E7A-4519-A44B-3E4809A7F658Q36137988-303E6EEE-4379-41CA-A6A9-2AC76BDB061BQ36813745-1844CBFC-7CCD-4FC7-BE83-DFA2E2386F7EQ36965275-F9ED8562-8781-4732-B42C-3BB58F9BDC62Q36983354-6D338594-F2C9-4016-89F8-196AEEE38FDCQ37241079-EAD9E23C-499A-469F-9F1C-36790B4A5899Q37337058-4AE99CB5-5B02-415A-9AD4-D9543D10CA5CQ38379042-78C25BAE-A567-44FE-AA28-059C8FCE940AQ38881707-FE4B44A7-ECCE-49A6-8595-9CE20439C0B0Q40353868-5AEC12E0-BED1-4155-8538-585A02AAA3BDQ41145658-807EB10D-365A-40D2-B42C-9F72B3C79E53Q41488070-02417505-DB6C-4068-AE87-B1C2582ACE70Q41949585-2FFCE41C-68FD-494C-AF5D-5B6623BCD2E0Q42056797-59DF85F1-AA3D-47C9-A074-083927304F3BQ42685032-7775AC15-79A6-4F32-86A6-B5C4D5DED956Q43006105-C9D89A65-690C-4DEC-A0F5-FC816060A397Q45223589-F412F989-8275-497B-8D98-638B69969B8CQ49458182-62BD2DEF-1CD4-4B72-9164-500C44CCB558
P2860
Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@ast
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@en
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@nl
type
label
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@ast
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@en
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@ast
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@en
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis.
@nl
P2093
P1476
Impaired spinal cord glutamate ...... amyotrophic lateral sclerosis
@en
P2093
David S Howland
H Beal McIlvain
John Dunlop
P304
P356
10.1523/JNEUROSCI.23-05-01688.2003
P407
P577
2003-03-01T00:00:00Z